The read data for the pairs of duplicate samples for the P. stewartii wild-type, ΔrcsA, and ΔlrhA strains, have been deposited in the NCBI Sequence Read Archive (SRA) with accession numbers, GSM1691841, GSM1691842, GSM1691843, GSM1691844, GSM1691845 and GSM1691846, respectively. An Excel file summarizing the differential gene expression in total counts and normalized reads per million (RPM), using the P. stewartii DC283 version 8 NCBI gene annotations, has been deposited in the NCBI Gene Expression Omnibus (GEO) database (GEO Accession GSE69064).

Introduction {#sec001}
============

*Pantoea stewartii* subsp. *stewartii* (*P*. *stewartii*) is a Gram-negative rod-shaped, gamma-proteobacterium that belongs to the *Enterobacteriaceae* family containing plant-associate enterics (eg. *Erwinia*, *Dickeya*, and *Pectobacterium* spp.) and human enteric pathogens associated with plants (eg. *Escherichia* and *Salmonella* spp.). *P*. *stewartii* is the causative agent of Stewart's wilt in maize \[[@pone.0145358.ref001]\]. It is transmitted passively from the gut of the corn flea beetle, *Chaetocnema pulicaria*, to the plant leaves via the feeding process of the insect vector \[[@pone.0145358.ref002]\]. The symptoms of the disease include water-soaked lesions in the leaf when the bacterium is in the apoplast during the early stages of infection and wilt due to biofilm formation in the xylem during the later stages of infection; ultimately this can lead to plant death \[[@pone.0145358.ref003]\]. The virulence of the bacterium is controlled through quorum sensing (QS) \[[@pone.0145358.ref004]\], a cell-to-cell communication system found primarily in eubacteria.

Gamma-proteobacteria, like *P*. *stewartii*, most commonly produce N-acyl homoserine lactone (AHL) signals during QS due to the activity of a LuxI-type protein. This intercellular signal then interacts with the master regulatory protein in the bacterium, a LuxR-type protein, to coordinate global gene expression. A variety of physiological outputs are controlled by QS such as bioluminescence, biofilm formation, virulence factor expression or exoenzyme production \[[@pone.0145358.ref005]--[@pone.0145358.ref009]\]. In *P*. stewartii, the QS signal N-3-oxo-hexanoyl-L-homoserine lactone (3-oxo-C~6~-HSL) is synthesized by the AHL synthase EsaI, a LuxI homologue \[[@pone.0145358.ref010]\]. At low cell density, the master QS regulatory protein EsaR, a LuxR homologue, is active and binds its recognition sites in the DNA to repress or activate transcription of different gene targets \[[@pone.0145358.ref010]--[@pone.0145358.ref012]\]. However, when EsaR and AHL form a complex, EsaR becomes inactive and unable to bind to DNA resulting in derepression or deactivation of target gene transcription at high cell density \[[@pone.0145358.ref013]\]. Several direct targets of EsaR have been identified through classic genetic \[[@pone.0145358.ref004]\], proteome-level \[[@pone.0145358.ref014]\] and transcriptome-level \[[@pone.0145358.ref015]\] analysis. Two of these direct targets, *rcsA* and *lrhA*, encode transcription factors elucidating additional levels of downstream regulation in response to QS.

RcsA is a transcription factor in the Rcs (regulation of capsule synthesis) regulatory network involved in colanic acid and K antigen capsular polysaccharide synthesis (cps) in *Escherichia coli* \[[@pone.0145358.ref016], [@pone.0145358.ref017]\] and *Salmonella typhi* \[[@pone.0145358.ref018]\]. It has been established that a major virulence factor of *P*. *stewartii*, the exopolysaccharide (EPS), is controlled via direct EsaR-mediated repression of *rcsA* (CKS_2570) \[[@pone.0145358.ref004]\]. Avirulent strains lacking EPS production typically have disruptions in genes found in either *rcsA* or the *cps* locus \[[@pone.0145358.ref004]\]. In *P*. *stewartii*, RcsA (in conjunction with RcsB) has been proposed to activate three *cps/wce* gene clusters, comprised of (I) *wceG1*, *wza*, *wzb*, *wzc*, *wceL*, *wceB*, *wceM*, *wceN*, *wceF*, *wceJ*, *wceK*, *wzx*, *galF*, and *galE*, (II) *wceG2* and (III) *wceO and wzx* \[[@pone.0145358.ref004], [@pone.0145358.ref019]\]. However, the complete RcsA regulon in *P*. *stewartii* has not been fully defined.

The LysR-type regulator LrhA (CKS_2075) is directly activated by EsaR in *P*. *stewartii* \[[@pone.0145358.ref014], [@pone.0145358.ref015]\]. In *E*. *coli*, LrhA indirectly controls expression of flagella, motility and chemotaxis by positively autoregulating its own expression and repressing the synthesis of the master regulator of flagella and chemotaxis gene expression, the FlhD~2~C~2~ heterotetramer, thereby suppressing motility and chemotaxis \[[@pone.0145358.ref020]\]. *P*. *stewartii* possesses swarming rather than swimming motility, and swarming motility is critical to the pathogenicity of the bacterium \[[@pone.0145358.ref021]\]. QS controls this motility in an interesting and complicated manner; a lack of AHL inhibits the motility, while lacking both AHL and EsaR attenuates swarming. It has been proposed that QS indirectly controls motility via stewartan synthesis regulated by the RcsA/B phosphorelay system \[[@pone.0145358.ref021]\]. Expression of the FlhD~2~C~2~ flagellar master regulator is directly control by the RcsA/B system in other bacteria \[[@pone.0145358.ref022]--[@pone.0145358.ref024]\]. However, the precise role of LrhA in *P*. *stewartii* and its relationship to both motility and RcsA is largely undefined.

To elucidate the downstream roles of RcsA and LrhA, phenotypic assays, RNA-Seq, qRT-PCR, GFP assays, and *in planta* virulence assays were used to evaluate the differences between the *rcsA* and *lrhA* deletion strains in comparison to the wild type. The identification of the most positively and negatively regulated targets for these two key downstream transcription factors provides greater insight into the coordinated regulation of genes in the QS network.

Materials and Methods {#sec002}
=====================

Strains and growth conditions {#sec003}
-----------------------------

Strains and plasmids utilized in this study are listed in [Table 1](#pone.0145358.t001){ref-type="table"}. *E*. *coli* strains were grown in Luria-Bertani (LB) (10 g/L tryptone, 5 g/L yeast extract, and 5 g/L NaCl) broth or on plates with 1.5% agar and *P*. *stewartii* strains were grown in either LB or Rich Minimal (RM) medium (1X M9 salts, 2% casamino acids, 1 mM MgCl~2~, and 0.4% glucose). The growth medium was supplemented with nalidixic acid (Nal, 30 μg/ml), ampicillin (Ap, 100 μg/ml), kanamycin (Kn, 50 μg/ml), chloramphenicol (Cm, 30 μg/ml), or streptomycin (Str, 100 μg/ml) as required (see [Table 1](#pone.0145358.t001){ref-type="table"}). *P*. *stewartii* strains were grown at 30°C, while *E*. *coli* strains were maintained at 37°C.

10.1371/journal.pone.0145358.t001

###### Strains and plasmids used in the study.

![](pone.0145358.t001){#pone.0145358.t001g}

  Strains                           Genotype and notes[^a^](#t001fn001){ref-type="table-fn"}                                                                                   References
  --------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------
  ***Pantoea stewartii* strains**                                                                                                                                              
  DC283                             Wild-type strain; Nal^r^                                                                                                                   \[[@pone.0145358.ref026]\]
  *ΔlrhA*                           Unmarked deletion of *lrhA* coding sequence; Nal^r^                                                                                        This study
  Δ*lrhA/lrhA* ^*+*^                DC283 *ΔlrhA* with chromosomal complementation of *lrhA* and its promoter downstream of *glmS*; Nal^r^ Cm^r^                               This study
  Δ*rcsA*                           Unmarked deletion of *rcsA* coding sequence; Nal^r^                                                                                        This study
  Δ*rcsA/rcsA* ^+^                  DC283 *ΔrcsA* with chromosomal complementation of *rcsA* and its promoter downstream of *glmS*; Nal^r^ Cm^r^                               This study
  ***Escherichia coli* strains**                                                                                                                                               
  Top 10                            F^---^ *mcrA* Δ(*mrr-hsdRMS-mcrBC*) *Φ80dlacZΔM15* Δ*lac*X74 *deoR recAI araD139* Δ(*ara-leu)7697 galU galK rpsL (*Str^r^ *) endA1 nupG*   \[[@pone.0145358.ref045]\]
  DH5α                              *F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169*, *hsdR17(rK- mK+)*                                    \[[@pone.0145358.ref046]\]
  DH5α *λpir*                       *F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZΔM15 Δ(lacZYA-argF)U169*, *hsdR17(rK- mK+)*, *λpir*                            \[[@pone.0145358.ref025]\]
  CC118 *λpir*                      *Δ(ara-leu)*, *araD*, *ΔlacX74*, *galE*, *galK*, *phoA20*, *thi-1*, *rpsE*, *rpoB*, *argE(Am)*, *recA1*, *λpir*                            \[[@pone.0145358.ref027]\]
  S17-1 *λpir*                      *recA pro hsdR RP4-2-Tc*::*Mu-Km*::*Tn7*                                                                                                   \[[@pone.0145358.ref031]\]
  **Plasmids**                                                                                                                                                                 
  pGEM-T                            Cloning vector, Ap^r^                                                                                                                      Promega
  pDONR201                          Entry vector in the Gateway system, Kn^r^                                                                                                  Life Technologies
  pAUC40                            Suicide vector pKNG101::*attR*-*ccdB*-Cm^R^; Cm^r^, Str^r^, *sacB*                                                                         \[[@pone.0145358.ref019]\]
  pEVS104                           Conjugative helper plasmid, *tra trb;* Kn^r^                                                                                               \[[@pone.0145358.ref028]\]
  pUC18R6K-mini-Tn7-cat             Tn7 vector for chromosomal integration into the intergenic region downstream of *glmS*; Cm^r^, Ap^r^                                       \[[@pone.0145358.ref030]\]
  pPROBE'GFP\[tagless\] P~*rcsA*~   pPROBE'GFP\[tagless\] vector with the promoter of *rcsA;* Kn^r^                                                                            This study

^*a*^ Ap^**r**^, ampicillin resistance; Nal^**r**^, nalidixic acid resistance; Kn^r^, kanamacyin resistance; Gm^r^, gentamycin resistance; Cm^r^, chloramphenicol resistance; Str^r^, streptomycin resistance

Construction of markerless deletion mutant strains {#sec004}
--------------------------------------------------

Chromosomal deletions of *lrhA* and *rcsA* were constructed based on the Gateway system (Life Technologies, Grand Island, NY) and suicide vectors. Two 1kb fragments from upstream and downstream of the desired deletion region were first separately amplified using the primers designated in [S1 Table](#pone.0145358.s001){ref-type="supplementary-material"}. After that, a two-step PCR reaction was performed in which the upstream and downstream segments for the specific gene were joined together and primers 1kbUPF-attB1 and 1kbDNR-attB2 ([S1 Table](#pone.0145358.s001){ref-type="supplementary-material"}), specific to each construct, were added to facilitate the Gateway BP reaction (Life Technologies). The final PCR products were cloned into the pGEM-T vector (Promega, Madison, WI) for sequencing before being transferred to the Gateway plasmids using BP Clonase II enzyme mix and then to the suicide vector pAUC40 \[[@pone.0145358.ref019]\] using LR Clonase II enzyme mix (Life Technologies). The resulting plasmids were transformed into competent *E*. *coli* DH5α *λ pir* cells \[[@pone.0145358.ref025]\]. A tri-partite conjugation was used to transfer the suicide vector constructs into *P*. *stewartii* DC283 \[[@pone.0145358.ref026]\] using *E*. *coli* strain CC118*λpir* \[[@pone.0145358.ref027]\] carrying the conjugative helper plasmid pEVS104 \[[@pone.0145358.ref028]\] to facilitate suicide vector transfer. Selection for the first recombination event into the *P*. *stewartii* chromosome was carried out on LB agar supplemented with Nal and Str. Then, the recombinants were plated on LB (no salt) agar supplemented with 5% sucrose \[[@pone.0145358.ref029]\] to select for the desired double cross-over based on SacB activity. A screen for deletion strains was performed with colony PCR using a 3-primer reaction with primers for each gene corresponding to sites upstream, downstream, and inside the specific gene of interest ([S1 Table](#pone.0145358.s001){ref-type="supplementary-material"}). DNA sequencing of appropriate PCR products was used to confirm the final deletion strains.

Construction of chromosomal complementation strains {#sec005}
---------------------------------------------------

Complementation strains were constructed by generating a chromosomal insertion of the promoter and coding regions of the target gene into the neutral region downstream of *glmS* on the *P*. *stewartii* chromosome using the pUC18R6K-mini-Tn7-cat vector system developed by Choi *et al* \[[@pone.0145358.ref030]\]. Specifically, primer sets with either *Eco*RI and *Xho*I or *Sac*I and *Spe*I sites ([S1 Table](#pone.0145358.s001){ref-type="supplementary-material"}) were used to amplify the target regions and clone them into pGEM-T (Promega) for sequencing confirmation. DNA fragments of interest were moved into the pUC18R6K-mini-Tn7-cat vector using double digestion with *Eco*RI and *Xho*I or *Sac*I and *Spe*I (New England BioLabs (NEB), Ipswich, MA), followed by ligation with T4 DNA ligase (NEB) and transformation into DH5α *λpir* or S17-1 *λpir* \[[@pone.0145358.ref031]\]. These transformants served as the donor in the conjugation process with the appropriate deletion strain of *P*. *stewartii* as the recipient. Colony PCR reactions using one primer in the inserted gene and two primers flanking the *glmS* region \[[@pone.0145358.ref032]\] were conducted to screen for the presence of the chromosomal insertion. DNA sequencing of appropriate PCR products was used to validate the integrity of the complementation strains.

Phenotypic capsule production assay {#sec006}
-----------------------------------

Wild-type, Δ*rcsA* and Δ*rcsA/rcsA* ^*+*^ strains were grown in LB supplemented with the appropriate antibiotics overnight at 30°C with shaking. The overnight cultures were used to inoculate fresh LB to an OD~600~ of 0.05 and grown at 30°C to OD~600~ of 0.2. The strains were then cross streaked on agar plates containing 0.1% casamino acids, 1% peptone, 1% glucose (CPG) and 1.5% agar \[[@pone.0145358.ref012]\]. Capsule production was assessed qualitatively after 48 hours of incubation at 30°C by visually comparing the surface appearance of the streaks.

Phenotypic surface motility assay {#sec007}
---------------------------------

Swarming motility for the wild-type, Δ*lrhA*, and Δ*lrhA/lrhA* ^*+*^ strains was investigated under strict conditions to ensure a reproducible phenotype. Overnight cultures were diluted to an OD~600~ of 0.05 in LB broth and grown to an OD~600~ of 0.5. Five μl of cell culture at OD~600~ of 0.5 were spotted directly onto the agar surface of LB 0.4% agar quadrant plates supplemented with 0.4% glucose \[[@pone.0145358.ref021]\], which were poured on the same day of the experiment. Plates were put at room temperature for 30 min to 1 hour before incubating them lid-up in a closed box with a flat bottom inside the 30^°^C incubator. Pictures of the plates were taken after 48 hours of incubation.

Transcriptome analysis methods {#sec008}
------------------------------

The RNA-Seq method for analyzing the transcriptome of the wild-type *P*. *stewartii* DC283 strain and the two strains each carrying a deletion of one of the two genes, *lrhA* or *rcsA*, has been previously published \[[@pone.0145358.ref015]\]. Briefly, RNA was extracted from duplicate samples of each strain separately grown in RM medium using a Qiagen (Valencia, CA) miRNeasy RNA extraction kit. The total bacterial RNA was sent to the Virginia Bioinformatics Institute (VBI) (Virginia Tech, Blacksburg, VA) for Bioanalyzer quality analysis to insure RIN values greater than 9. The rRNA was depleted with an Epicentre (Madison, WI) Ribo-Zero Gram-negative Depletion Kit prior to Illumina (San Diego, CA) cDNA conversion and Illumina sequencing with single 50 bp reads.

RNA-Seq Data analysis and qRT-PCR validation {#sec009}
--------------------------------------------

Data in the form of fastq files was received and aligned to the *P*. *stewartii* DC283 version 8 draft genome from NCBI (NZ_AHIE00000000.1) using the Geneious 7.0 software with the default "low sensitivity" settings, which also counted the numbers of reads aligning to each protein coding gene (excluding the highly repeated genes annotated as "transposase" or "IS66 ORF2 family protein"). Microsoft Excel was then used to compute an expression level for each gene by simply normalizing the read counts for each gene to the total number of mapped reads per million mapped reads (RPM) for each sample. Then the ratio of the RPM expression values (averaged over the two biological replicates) was used to compare the wild-type and deletion strain gene expression levels. (The raw read counts and RPM normalized expression levels for each of the four samples are available in the NCBI GEO database: Accession \# GSE69064.) This analysis was used to select genes for qRT-PCR confirmation and validation of the RNA-Seq data. The validation genes were required to have (1) a greater than a four-fold change in average expression (RPM) between the two strains (wild-type and deletion), (2) greater than 100 reads mapped to the reference coding sequence in at least one of the samples and (3) reproducible levels of expression (\< two fold change) in duplicate trials. The Bioconductor R software package "DESeq" \[[@pone.0145358.ref033]\] was also used to analyze the raw read counts using a more sophisticated gene expression normalization and error model to calculate multiple testing adjusted pvalues to estimate the statistical significance of detected gene expression changes. The fold changes (DESeq foldchange) determined by this second method were very similar to our Microsoft Excel analysis for the genes with 4-fold or greater change and the adjusted pvalues (DESeq padj) for those genes selected for qRT-PCR validation were all less than 0.012 (Tables [2](#pone.0145358.t002){ref-type="table"} and [3](#pone.0145358.t003){ref-type="table"}).

10.1371/journal.pone.0145358.t002

###### List of genes differentially expressed 4-fold or more in the Δ*rcsA* RNA-Seq data.

![](pone.0145358.t002){#pone.0145358.t002g}

  Accession \#            Locus_tag   GeneID    Product                                                             RPM Fold Change   DESeq Fold Change   DESeq padj
  ----------------------- ----------- --------- ------------------------------------------------------------------- ----------------- ------------------- ------------
  **Activated by RcsA**                                                                                                                                   
  ACV-0288878             CKS_4672              secreted protein                                                    17.69             16.08               1.2E-01
  ACV-0289544             CKS_2241    *wceG1*   undecaprenyl-phosphate UDP-galactose phosphotransferase             12.60             11.89               2.1E-15
  ACV-0290198             CKS_2799    *osmB*    lipoprotein                                                         9.12              8.08                1.0E+00
  ACV-0286879             CKS_2708    *wceG2*   undecaprenyl-phosphate UDP-galactose phosphotransferase             7.78              7.47                2.7E-08
  ACV-0288877             CKS_4671              putative outer membrane lipoprotein                                 7.44              6.99                5.2E-09
  ACV-0289541             CKS_2244    *wza*     polysaccharide export protein                                       6.26              5.75                1.2E-02
  ACV-0288876             CKS_4670              YmcB family protein                                                 5.79              5.53                3.0E-07
  ACV-0289540             CKS_2245    *wzb*     phosphotyrosine-protein phosphatase                                 5.16              4.74                6.2E-02
  ACV-0289539             CKS_2246    *wzc*     tyrosine-protein kinase                                             5.13              4.70                2.8E-02
  ACV-0288191             CKS_4022    *wceO*    beta-16-glucosyltransferase                                         4.75              4.46                6.3E-06
  ACV-0289534             CKS_2251    *wceF*    exopolysaccharide biosynthesis protein                              4.11              3.78                9.7E-02
  **Repressed by RcsA**                                                                                                                                   
  ACV-0290191             CKS_2806              putative formate dehydrogenase oxidoreductase protein               50.38             54.64               5.7E-34
  ACV-0289299             CKS_3504              cytosine/purine/uracil/thiamine/allantoin permease family protein   8.85              9.44                1.3E-11
  ACV-0289953             CKS_1065    *argC*    N-acetyl-gamma-glutamylphosphate reductase                          5.25              5.50                8.6E-08
  ACV-0289954             CKS_1064    *argB*    acetylglutamate kinase                                              5.14              5.46                2.3E-07
  ACV-0291072             CKS_1283    *cysD*    sulfate adenylyltransferase subunit 2                               5.07              5.57                3.0E-07
  ACV-0291071             CKS_1282    *cysN*    sulfate adenylyltransferase subunit 1                               4.29              4.64                4.7E-06
  ACV-0289145             CKS_4942    *argI*    ornithine carbamoyltransferase 1                                    4.20              4.54                1.1E-05

10.1371/journal.pone.0145358.t003

###### List of genes differentially expressed 4-fold or more in the Δ*lrhA* RNA-Seq data.
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  Accession \#            Locus_tag   GeneID   Product                                                     RPM Fold Change   DESeq Fold Change   DESeq padj
  ----------------------- ----------- -------- ----------------------------------------------------------- ----------------- ------------------- ------------
  **Activated by LrhA**                                                                                                                          
  ACV-0289574             CKS_2211             hypothetical protein                                        7.45              6.97                7.9E-04
  ACV-0288191             CKS_4022    *wceO*   beta-16-glucosyltransferase                                 7.43              6.80                3.7E-11
  ACV-0291275             CKS_3793             cytochrome d ubiquinol oxidase subunit I                    4.72              4.30                3.4E-05
  **Repressed by LrhA**                                                                                                                          
  ACV-0287751             CKS_5211             putative alpha/beta superfamily hydrolase/acyltransferase   58.54             61.87               8.5E-13
  ACV-0287748             CKS_5208             rhamnosyltransferase I subunit B                            17.02             18.57               2.0E-05
  ACV-0290189             CKS_2808             hypothetical protein                                        15.00             16.26               3.5E-16
  ACV-0285926             CKS_2106             hypothetical protein                                        11.06             11.98               5.4E-17
  ACV-0285999             CKS_2612             phage holin                                                 8.80              9.15                3.5E-14
  ACV-0290526             CKS_0458             putative fimbrial subunit                                   8.39              9.32                1.1E-09
  ACV-0286015             CKS_2628             hypothetical protein                                        6.69              7.14                2.9E-09
  ACV-0286005             CKS_2618             hypothetical protein                                        6.46              6.83                3.4E-04
  ACV-0286003             CKS_2616             phage protein                                               5.73              5.92                5.4E-04
  ACV-0286012             CKS_2625             hypothetical protein                                        5.58              5.79                9.5E-03
  ACV-0286019             CKS_2632             hypothetical protein                                        5.53              5.67                3.3E-02
  ACV-0286011             CKS_2624             hypothetical protein                                        5.51              5.77                1.3E-07
  ACV-0286029             CKS_2642             hypothetical protein                                        5.46              5.63                1.1E-04
  ACV-0286016             CKS_2629             phage tail sheath protein FI                                5.14              5.49                6.4E-09
  ACV-0290525             CKS_0459             putative fimbrial subunit                                   5.02              5.57                2.1E-08
  ACV-0290434             CKS_0551             carbonic anhydrase                                          4.84              5.25                5.9E-08
  ACV-0286009             CKS_2622             hypothetical protein                                        4.77              5.17                3.6E-03
  ACV-0286013             CKS_2626             hypothetical protein                                        4.29              4.60                3.4E-05
  ACV-0286031             CKS_2644             hypothetical protein                                        4.29              4.57                3.5E-04
  ACV-0286018             CKS_2631             hypothetical protein                                        4.27              4.44                1.4E-01
  ACV-0286014             CKS_2627             hypothetical protein                                        4.26              4.47                7.7E-03
  ACV-0286028             CKS_2641             phage baseplate assembly protein V                          4.17              4.55                1.4E-02
  ACV-0286022             CKS_2635             hypothetical protein                                        4.00              4.14                3.4E-05

The qRT-PCR method used for RNA-Seq validation has been previously described in Ramachandran et al \[[@pone.0145358.ref015]\]. Briefly, each strain was grown in the same manner as for RNA-Seq. RNA was extracted using a miRNeasy RNA extraction kit (Qiagen) and converted to cDNA using the ABI High Capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific, Waltham, MA). Primers ([S2 Table](#pone.0145358.s002){ref-type="supplementary-material"}) designed using Primer Express software (ABI) were optimized and used to amplify \~100 bp regions of each gene of interest to determine the abundance of each transcript. The Pfaffl method was used to compare the wild type versus mutant abundance of a transcript to determine the fold regulation \[[@pone.0145358.ref034]\].

GFP fusion construction and testing {#sec010}
-----------------------------------

A transcriptional fusion between the *rcsA* promoter and the gene for green fluorescent protein (GFP) was created using traditional molecular techniques. The *rcsA* promoter is located within the region -600 bp upstream of the annotated translation initiation codon \[[@pone.0145358.ref035]\]. The restriction sites *Eco*RI and *Kpn*I were added to the 5' and 3' ends of the promoter sequence, respectively, through the PCR primers ([S1 Table](#pone.0145358.s001){ref-type="supplementary-material"}). The PCR-amplified promoter fragment was ligated into pGEM-T (Promega) and sequenced. After restriction digestion of the pGEM-T construct and pPROBE'-GFP- \[tagless\] vector \[[@pone.0145358.ref036]\], a ligation produced the final pPROBE'-GFP-\[tagless\] vector containing the *rcsA* promoter. *E*. *coli* DH5α was transformed with this plasmid construct which was then moved into wild-type *P*. *stewartii* DC283 via conjugation using a triparental mating with the pEVS104 helper plasmid. The conjugation plates were scanned using a Typhoon Trio Scanner (GE Healthcare, Pittsburgh, PA) set to use the blue laser to screen for GFP production. Subsequently, the Δ*lrhA* and Δ*lrhA/lrhA* ^*+*^ strains were conjugated to receive the same P~*rcsA*~ pPROBE'-GFP-\[tagless\] vector creating the desired reporter strains.

The transconjugates were grown in RM medium supplemented with Nal and Kn, overnight to an OD~600~ \< 0.5 and then diluted in fresh RM to an OD~600~ of 0.025. The cultures were allowed to grow at 30°C with shaking at 250 RPM to an OD~600~ 0.5. The GFP production was monitored in 96-well plates using a Tecan Infinite 200 (Durham, NC) set with 485 excitation and 535 emission filters. The three strains were each analyzed in triplicate for one experiment, and the three wells were averaged together to establish the mean fluorescence. The average fluorescence reading from the blank was subtracted from the average fluorescence of each strain tested to remove background signal due to the medium. The normalized fluorescence was then divided by the OD~600~ for the sample to yield relative fluorescence readings/ OD~600~. The three average relative fluorescence readings/ OD~600~ from three different experiments were averaged together and the overall standard error and two-tailed homoscedastic Student's t-test values calculated.

Plant virulence assay {#sec011}
---------------------

The procedure for conducting the virulence assays with *P*. *stewartii* strains in *Zea mays* seedlings was adapted from von Bodman et al. \[[@pone.0145358.ref012]\] with some modifications. Sweet corn seedlings (*Zea mays* cv. Jubilee, HPS Seed, Randolph, WI) were grown in Sunshine mix \#1 soil in an growth chamber (Percival Scientific, Inc., Boone, IA) at 28°C, 80% relative humidity, 16 hours light and eight hours dark cycle, and at least 200 mE m^-2^ s^-1^ light intensity. Seedlings were inoculated seven days after planting with five μl of bacterial culture grown to an OD~600~ of 0.2 in LB broth. Cells were washed and resuspended in an equal volume of phosphate buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~ and 2 mM KH~2~PO~4~, pH 7.4) prior to plant inoculation. An incision \~1 cm long was made \~1 cm above the soil line in the stem using a sterile needle (26 G 5/8, 15.9 mm, SUB-Q, Becton, Dickinson and Company, US). Then, the bacterial suspension was inoculated into the wound by moving the pipette tip across the wound five times. Fifteen germinated plants at day seven with two separate leaves and between 6--10 cm of height were inoculated for each bacterial strain tested. The plants were observed every other day after inoculation for up to 12 days post-infection to assess the virulence by two independent observers. Disease symptom severity was scored based on an arbitrary scale of five points, in which 0 = no symptoms; 1 = few scattered lesions; 2 = scattered water soaking symptoms; 3 = numerous lesions and slight wilting; 4 = moderately severe wilt; 5 = death. Both scores for each of the 15 plants under each treatment were averaged and then the data for each treatment were averaged together and used to calculate mean and standard error across the 15 plants.

Accession numbers {#sec012}
-----------------

The read data for the pairs of duplicate samples for the *P*. *stewartii* wild-type, Δ*rcsA*, and Δ*lrhA* strains, have been deposited in the NCBI Sequence Read Archive (SRA) with accession numbers, GSM1691841, GSM1691842, GSM1691843, GSM1691844, GSM1691845 and GSM1691846, respectively. An Excel file summarizing the differential gene expression in total counts and normalized reads per million (RPM), using the *P*. *stewartii* DC283 version 8 NCBI gene annotations, has been deposited in the NCBI Gene Expression Omnibus (GEO) database (GEO Accession GSE69064).

Results {#sec013}
=======

Deletion of *rcsA* or *lrhA* impacts phenotypic outputs {#sec014}
-------------------------------------------------------

Cross streaks of the *P*. *stewartii* wild-type, Δ*rcsA* and Δ*rcsA/rcsA* ^*+*^ strains on CPG agar demonstrated that deletion of *rcsA* yielded an easily visible decrease in the level of capsule production ([Fig 1A](#pone.0145358.g001){ref-type="fig"}). Chromosomal complementation of *rcsA* restored capsule synthesis to levels similar to the wild type ([Fig 1A](#pone.0145358.g001){ref-type="fig"}).

![Impact of RcsA and LrhA on phenotype of *P*. *stewartii*.\
Panel A shows an analysis of capsule production in *P*. *stewartti* DC283 wild-type, Δ*rcsA* mutant and Δ*rcsA/rcsA* ^*+*^ complementation strains (left to right). Differences in capsule production are apparent in the regions between the arms of the X-cross streak. Panel B shows an analysis of swarming motility in wild-type, Δ*lrhA* mutant and Δ*lrhA/lrhA* ^*+*^ complementation strains (left to right). All pictures for panel A or B, respectively, were taken at the same magnification after 48 hours of incubation.](pone.0145358.g001){#pone.0145358.g001}

Separately, the *P*. *stewartii* wild-type, Δ*lrhA* and Δ*lrhA/lrhA* ^*+*^ strains were analyzed for motility. Under the test conditions employed, the wild-type strain exhibited unidirectional expansion the majority of the time as described by Herrera *et al* \[[@pone.0145358.ref021]\] ([Fig 1B](#pone.0145358.g001){ref-type="fig"}), but sometimes a more symmetrical expansion was observed. The Δ*lrhA* strain exhibited a different phenotype with a noticeably smaller occupied surface area ([Fig 1B](#pone.0145358.g001){ref-type="fig"}). Two chromosomally complemented strains of the Δ*lrhA* strain were constructed because a smaller promoter region (\~600 bp upstream of *lrhA* coding region) strain could not complement the deletion (data not shown) whereas the strain with almost the entire intergenic region upstream of *lrhA* gene (\~921 bp upstream) could ([Fig 1B](#pone.0145358.g001){ref-type="fig"}). This suggests that there are critical regulatory elements more than 600 bp upstream in the *lrhA* promoter region.

RNA-Seq analysis reveals the RcsA and LrhA regulons {#sec015}
---------------------------------------------------

RNA-Seq data was acquired in duplicate for the *P*. *stewartii* wild-type, Δ*rcsA*, and Δ*lrhA* strains to analyze the global impact of the two regulators. Each strain yielded 17 to 19 million reads that were mapped to the protein coding genes on the *P*. *stewartii* DC283 genome (NZ_AHIE00000000.1). The normalized gene expression data (RPM) from the two trials was averaged and then the deletion strains were compared to the wild-type strain to determine the changes in gene expression when each transcription regulator was absent ([Fig 2](#pone.0145358.g002){ref-type="fig"}). Genes with decreased expression in the deletion strains were considered to be positively regulated, either directly or indirectly, by RcsA or LrhA, respectively, in the wild-type strain. Conversely, genes with enhanced expression in the deletion strains were considered to be negatively regulated by the presence of LrhA or RcsA in the wild-type strain. A conservative four-fold change in RPM gene expression level was used as a selection criterion for genes to be further analyzed. An additional DESeq analysis supported the initial RPM data analysis. RcsA activates 11 genes and represses seven genes four-fold or greater ([Table 2](#pone.0145358.t002){ref-type="table"}) and LrhA activates three genes and represses 23 genes four-fold or greater ([Table 3](#pone.0145358.t003){ref-type="table"}). The most highly regulated RcsA-regulated genes are primarily related to capsule production, an activity previously shown to be under RcsA control \[[@pone.0145358.ref004]\]. The most highly regulated genes in the LrhA regulon are mostly hypothetical proteins or proteins with just putative gene function. Interestingly, a 3.04-fold repression of *rcsA* by LrhA was detected during the RNA-Seq analysis hinting at a possible coordination of regulation between RcsA and LrhA.

![Differential mRNA expression during QS.\
Whole transcriptome data of the *P*. *stewartii* DC283 wild-type strain compared to the Δ*rcsA* strain (panel A) or the Δ*lrhA* strain (panel B). An open circle is used to represent each gene. Those filled with green are activated (levels of expression are four-fold or lower in the deletion strain) and those filled with red are repressed (levels of expression are four-fold or higher in the deletion strain), by either RcsA (panel A) or LrhA (panel B). The two extreme outlier points, with RPM expression \>100 in the wild-type and \~1 in the deletion strains, represent the deleted genes *rcsA* or *lrhA*, respectively. All of the other colored points with RPM expression \>1 in both samples are tabulated in Tables [2](#pone.0145358.t002){ref-type="table"} and [3](#pone.0145358.t003){ref-type="table"}. The RPM change of normalized expression for most genes fall tightly around a line of slope of 1, indicating that they are approximately equally expressed in both strains.](pone.0145358.g002){#pone.0145358.g002}

qRT-PCR validates the RNA-Seq data {#sec016}
----------------------------------

Following the initial analysis of the RNA-Seq results, five target genes were selected from each of the putative RcsA and LrhA regulons to validate the RNA-Seq data via qRT-PCR. Some of the most highly regulated genes (Tables [2](#pone.0145358.t002){ref-type="table"} and [3](#pone.0145358.t003){ref-type="table"}), which do not code for hypothetical proteins, were chosen for validation of the RNA-Seq data. The *rcsA* gene was also included in the analysis as its three-fold regulation by LrhA represented a potential feedback loop in the downstream QS system. The five genes tested for the RcsA regulon were: *wceG2*, *wza*, *argC*, CKS_3504, and CKS_2806. The five genes tested for the LrhA regulon were: CKS_3793, CKS_0458, CKS_5208, CKS_5211, and *rcsA*. The RNA-Seq data trends for the Δ*rcsA* and Δ*lrhA* strains were successfully validated by all five genes tested via qRT-PCR (Figs [3](#pone.0145358.g003){ref-type="fig"} and [4](#pone.0145358.g004){ref-type="fig"}). Although there was variability in the absolute values of the fold changes between the RNA-Seq and qRT-PCR results, the regulation for a given gene shows similar trends (activation or repression) using both approaches. The qRT-PCR data also confirmed the initial observation from the RNA-Seq data that LrhA is repressing *rcsA* expression about three-fold. The interplay between these specific components of the *P*. *stewartii* QS system was thus further examined to build a more robust model of interactions.

![Validating transcriptional control of select genes by RcsA.\
Changes in gene expression were compared between the RNA-Seq analysis (light grey) and qRT-PCR assays (dark grey) for five genes regulated by RcsA. Y-axis represents the fold activation (panel A) or repression (panel B) on a logarithmic scale in the presence of RcsA. RNA-Seq results are averages of two experimental samples and qRT-PCR data represent two experimental samples analyzed in triplicate. Error bars were estimated using the sample standard error of the fold-change across the two independent biological replicates for both RNA-Seq and qRT-PCR.](pone.0145358.g003){#pone.0145358.g003}

![Validating transcriptional control of select genes by LrhA.\
Changes in gene expression were compared between the RNA-Seq analysis (light grey) and qRT-PCR assays (dark grey) for five genes regulated by LrhA. Y-axis represents the fold activation (panel A) or repression (panel B) on a logarithmic scale in the presence of LrhA. RNA-Seq results are averages of two experimental samples and qRT-PCR data represent two experimental samples analyzed in triplicate. Error bars were estimated using the sample standard error of the fold-change across the two independent biological replicates for both RNA-Seq and qRT-PCR.](pone.0145358.g004){#pone.0145358.g004}

RcsA is controlled by LrhA {#sec017}
--------------------------

A *rcsA* promoter-GFP reporter transcription fusion was used to analyze expression of *rcsA* in *P*. *stewartii* DC283 wild-type, Δ*lrhA* and Δ*lrhA/lrhA* ^*+*^ strains ([Fig 5](#pone.0145358.g005){ref-type="fig"}). These experiments were performed at an OD~600~ of 0.5, the same growth conditions used for the RNA-Seq and qRT-PCR analysis. The relative fluorescence units (RFU) produced by the Δ*lrhA* strain were significantly more (*p*\< 0.05) than either the wild-type strain or the Δ*lrhA/lrhA* ^*+*^ strain, suggesting LrhA represses *rcsA* either directly or indirectly. The results of the GFP assays further verified that LrhA negatively regulates *rcsA*, confirming the existence of a previously unrecognized feedback loop in the regulatory circuitry downstream of EsaR in the QS network; it is now recognized that both EsaR and LrhA negatively regulate *rcsA*.

![Expression from the *rcsA* promoter.\
A GFP reporter was used to measure levels of transcription from the *rcsA* promoter. Strains were grown to an OD~600~ of 0.5 and the average fluorescence/OD~600~ was measured. As indicated by an asterisk, expression from the Δ*lrhA* strain is significantly higher (*p*\< 0.05) than either the wild-type strain or the Δ*lrhA/lrhA* ^*+*^ strain using a two-tailed homoscedastic Student's t-test. This indicates that LrhA normally represses expression of *rcsA* in the wild-type strain. Data represents three experimental samples analyzed in triplicate. Error bars denote standard error.](pone.0145358.g005){#pone.0145358.g005}

RcsA and LrhA are involved in plant virulence {#sec018}
---------------------------------------------

The virulence of the Δ*rcsA* and Δ*lrhA* strains was compared to the wild type and respective complemented strains in a xylem-infection system. At day twelve post-infection, plants infected with the wild-type strain exhibit typical symptoms of the wilting stage and had an average disease severity score of \~3.5 while negative control plants infected with PBS were healthy with a score of \~0. The Δ*rcsA* strain also did not cause any severe disease symptoms with a score of \~0, while the Δ*lrhA* strain expressed an intermediate level of virulence with a score of \~1.75 ([Fig 6](#pone.0145358.g006){ref-type="fig"}). The Δ*rcsA/rcsaA* ^*+*^ strain partially restored the virulence of *P*. *stewartii*, whereas the Δ*lrhA/lrhA* ^*+*^ strain fully complemented virulence. Both RcsA and LrhA clearly play roles in the pathogenicity of *P*. *stewartii*.

![Plant assays testing the role of RcsA or LrhA in virulence.\
Data shown is the average score of disease for Day 12 of an infection assay performed with 15 plants inoculated with *P*. *stewartii* DC283 strains: wild type (WT), Δ*rcsA*, Δ*rcsA/rcsA* ^*+*^, Δ*lrhA*, Δ*lrhA/lrhA* ^*+*^, or PBS as a negative control. The asterisks (\*) represent strains that are statistically significantly different (p\< 0.05) from the wild-type strain using a two-tailed homoscedastic Student's t-test. Error bars denote standard error.](pone.0145358.g006){#pone.0145358.g006}

Discussion {#sec019}
==========

Previous studies demonstrated that the quorum-sensing master regulator EsaR directly represses *rcsA* and directly activates *lrhA* transcription \[[@pone.0145358.ref015], [@pone.0145358.ref035]\]. As anticipated, phenotypic studies examining the impact of deletion of the genes encoding RcsA or LrhA resulted in noticeable effects on the production of capsule and the motility of *P*. *stewartii* cells, respectively. These important second-tier transcription factors downstream in the QS regulon were further examined for their role in global gene regulation via RNA-Seq analysis of gene expression in each of the two deletion strains compared with the wild-type strain. A qRT-PCR analysis confirmed that five genes for each deletion were regulated in the same manner shown by the RNA-Seq data. This allowed for increased confidence in the RNA-Seq data and the ability to draw more solid conclusions about the transcriptomes and the downstream network of gene regulation controlled by RcsA and LrhA.

Many of the most highly activated genes found in the RcsA regulon were related to capsule production: *wceG1*, *wceG2*, *wza*, *wzb*, *wzc*, *wceO*, *and wceF* ([Table 2](#pone.0145358.t002){ref-type="table"}). Previous work has demonstrated that RcsA directly activates the promoters of the *cps* gene cluster in both *E*. *coli* and *P*. *stewartii* \[[@pone.0145358.ref004], [@pone.0145358.ref016], [@pone.0145358.ref019]\]. In *E*. *coli*, RcsA is one of two colonic acid capsular polysaccharide transcriptional activators, it is also self-activating, degraded by Lon-proteases, and requires RcsB to activate *cps* genes \[[@pone.0145358.ref016], [@pone.0145358.ref037]\]. Similarly, in *P*. *stewartii* RcsA has been shown to activate genes required for EPS production as well as to self-activate its own gene \[[@pone.0145358.ref016], [@pone.0145358.ref035]\]. The RNA-Seq data also revealed additional genes in the *P*. *stewartii* RcsA regulon that are directly or indirectly suppressed by RcsA. Specifically, RcsA repressed several genes in the *cys* and *arg* operons more than four-fold ([Table 2](#pone.0145358.t002){ref-type="table"}). The *cys* genes are involved in sulfate activation, which leads to cysteine biogenesis in *E*. *coli* \[[@pone.0145358.ref038]\]. The genes *cysD* and *cysN* are in an operon and each encodes a subunit of the sulfate adenyltransferase complex \[[@pone.0145358.ref039], [@pone.0145358.ref040]\]. The *arg* genes are involved in arginine biosynthesis in *E*. *coli* \[[@pone.0145358.ref041], [@pone.0145358.ref042]\]. The three *arg* genes most regulated by RcsA are *argB* encoding acetylglutamate kinase, *argC* encoding N-acetyl-gamma-glutamylphosphate reductase, and *argI* encoding ornithine carbamoyltransferase. It is unclear why RcsA would repress the arginine and cysteine biosynthetic pathways and how this might relate to capsule production in *P*. *stewartii*.

*P*. *stewartii* LrhA is 77% identical at the amino acid level to its *E*. *coli* counterpart. In *E*. *coli*, LrhA is a LysR-type transcriptional factor negatively controlling motility, chemotaxis, flagellar biosynstheis \[[@pone.0145358.ref020]\] and type 1 fimbrial expression \[[@pone.0145358.ref043]\]. However, unlike *E*. *coli*, where LrhA highly represses some genes related to flagellar function and chemotaxis by approximately 3--80 fold \[[@pone.0145358.ref020]\], the *P*. *stewartii* RNA-Seq data only indicated a \~two- to three-fold level of repression. On the other hand, LrhA does repress expression of two putative fimbrial subunits (encoded by CKS_0458 and CKS_0459) more than four-fold in *P*. *stewartii* ([Table 3](#pone.0145358.t003){ref-type="table"} and [Fig 4](#pone.0145358.g004){ref-type="fig"}), while the *E*. *coli* K12 strain MG1655 genome (CP009685.1) does not contain homologues of these genes. Thus there are clear differences between the role of LrhA in *E*. *coli* and *P*. *stewartii*. Interestingly, the *P*. *stewartii* fimbrial subunit genes CKS_0458 and CKS_0459 were also previously found to be directly controlled by the master QS regulator EsaR \[[@pone.0145358.ref015]\]. This is another example of coordinated control of gene expression at more than one level in the *P*. *stewartii* QS regulatory network.

Other *P*. *stewartii* annotated genes regulated by LrhA include CKS_5208, encoding rhamnosyltransferase I subunit B (RhlB), which is repressed. This enzyme may be involved in surfactant production necessary to facilitate swarming motility. In addition, the gene most highly repressed by LrhA, CKS_5211, is located adjacent to CKS_5208 in the genome. Although originally annotated as a putative alpha/beta superfamily hydrolase/acyltransferase, CKS_5211 has very high homology with rhamnosyltransferase I subunit A (RhlA) of other sequenced strains of *Pantoea*. This further suggests an important role for LrhA in controlling surfactant production in *P*. *stewartii*. One annotated activated gene, CKS_3793, codes for cytochrome d ubiquinol oxidase subunit I, which presumably plays a role during aerobic respiration. The only other annotated gene found to be four-fold or more activated by LrhA was *wceO*, which is related to capsule synthesis and is also activated by RcsA, suggesting that its regulation is highly complex.

The RNA-Seq, qRT-PCR and transcriptional fusion experiments all confirmed the existence of a previously unknown feedback loop in the quorum-sensing network downstream of EsaR, with LrhA repressing RcsA. A developing model of this network suggests that there is tight coordinate control of key virulence factors in *P*. *stewartii* ([Fig 7](#pone.0145358.g007){ref-type="fig"}) \[[@pone.0145358.ref014], [@pone.0145358.ref015], [@pone.0145358.ref035]\] with the EsaR, RcsA, and LrhA proteins creating a coherent type three feed forward loop \[[@pone.0145358.ref044]\]. The repressive role exerted by EsaR on *rcsA* transcription appears to be reinforced by the negative regulation of *rcsA* exerted by the EsaR-activated gene product LrhA. Negative control of *rcsA* expression by LrhA likely helps repress capsule production in the bacterium until the correct temporal point in disease progression. Positive autoregulation of RcsA in *P*. *stewartii* \[[@pone.0145358.ref035]\] will result in higher levels of the protein that escape proteolysis by Lon \[[@pone.0145358.ref016]\], thereby reinforcing the signal to increase capsule production at high cell density \[[@pone.0145358.ref035]\]. Normally, QS tightly controls expression of *rcsA* so that the bacterium only produces high levels of capsule after migration to the xylem has occurred. If capsule is expressed too early, it can actually hinder the ability of *P*. *stewartii* to cause disease \[[@pone.0145358.ref004]\]. Alternatively, the Δ*rcsA* strain showed no sign of infection in the plant virulence assay. Thus if the bacterium is incapable of producing capsule it also cannot form a biofilm in the xylem. The complement of *rcsA* however only partially restored the virulence of the deletion strain, perhaps indicating how important precise fine-tuning of *rcsA* expression is to disease outcome. The Δ*lrhA* strain significantly decreased the virulence of *P*. *stewartii*, but not to the degree seen with the Δ*rcsA* strain. This may in part be due to the removal of one level of regulation of *rcsA*, but is also probably due to impacts on the adhesion and motility of the bacterium, an area of on-going research. Since RcsA controls capsule production in *P*. *stewartii* and capsule is a main virulence factor for the bacterium, it would make sense for it to be regulated at multiple points in the regulatory network to ensure that the bacteria successfully migrate to the xylem before capsule and biofilm production begins in the corn plant. The tight control of RcsA by QS and the downstream network of transcriptional regulators, including RcsA itself \[[@pone.0145358.ref035]\] and LrhA, help ensure the precise timing of disease progression.

![Model of the quorum-sensing regulatory network in *P*. *stewartii*.\
See the text for details. Solid lines indicate known direct regulatory control. Dashed lines indicate either direct or indirect control found in the present study. Arrows represent activation and T lines represent repression.](pone.0145358.g007){#pone.0145358.g007}
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